Ocular Surface Disease: From Bench to Bedside

Ocular Surface Disease (OSD) refers to a group of disorders affecting the outermost layer of the eye, including the cornea and conjunctiva. This encompasses a wide range of conditions, such as dry eye syndrome, blepharitis, and ocular allergies. OSD can lead to symptoms such as irritation, redness, tearing, and blurred vision, significantly impacting the patient's quality of life. Advancements in understanding the pathophysiology of OSD have led to developments in diagnostic and treatment modalities, bridging the gap from laboratory research to clinical practice. Diagnostic tools such as tear film osmolarity measurement, meibomian gland imaging, and inflammatory biomarker analysis aid in accurate assessment and personalized management strategies. Treatment approaches for OSD vary depending on the underlying cause and severity of the condition. This may include artificial tear supplementation, anti-inflammatory medications, lid hygiene practices, and in severe cases, surgical interventions such as punctal plugs or amniotic membrane transplantation.

  • Pathophysiology and Biomarkers
  • Diagnostic Innovations
  • Therapeutic Strategies
  • Translational Research and Clinical Implementation

    Related Conference of Ocular Surface Disease: From Bench to Bedside

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain

    Ocular Surface Disease: From Bench to Bedside Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in